CIK 0001420720
- Non-accelerated filer
- Smaller reporting company
iBio, Inc.
Sign in to watch- Ticker
- IBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262797813
- Phone
- +1 302-355-0650
- Business address
- 600 MADISON AVENUE, SUITE 1601, NEW YORK, NY, 10022-1737
- Former names
- iBio, Inc., iBioPharma, Inc., InB:Biotechnologies, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-20 | Arkowitz David Director | Grant or award · Stock Option (right to buy) | +13,500 | 13,500 | ||
| 2025-10-20 | Duran Felipe Chief Financial Officer | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2025-10-20 | Banjak Marc Chief Legal Officer | Grant or award · Stock Option (right to buy) | +55,000 | 55,000 | ||
| 2025-10-20 | Brenner Martin See Remarks | Grant or award · Stock Option (right to buy) | +180,000 | 180,000 | ||
| 2025-02-21 | Banjak Marc Chief Legal Officer | Grant or award · Stock Option (right to buy) | +71,000 | 71,000 | ||
| 2025-02-21 | Duran Felipe Chief Financial Officer | Grant or award · Stock Option (right to buy) | +84,700 | 84,700 | ||
| 2025-02-21 | Brenner Martin See Remarks | Grant or award · Stock Option (right to buy) | +230,700 | 230,700 | ||
| 2025-01-10 | Duran Felipe Chief Financial Officer | Purchase | +9,191 | $2.72 | $25K | 11,139 |
| 2025-01-10 | Brenner Martin See Remarks | Purchase | +9,191 | $2.72 | $25K | 18,316 |
| 2025-01-10 | Banjak Marc Chief Legal Officer | Purchase | +9,191 | $2.72 | $25K | 11,066 |
| 2025-01-10 | Arkowitz David Director | Purchase | +18,382 | $2.72 | $50K | 18,382 |
| 2025-01-10 | Clark William D Director | Purchase | +1,838 | $2.72 | $5K | 1,838 |
| 2025-01-10 | Parada Antonio Bernardino Guimaraes Director | Purchase | +183,823 | $2.72 | $500K | 183,823 |
| 2025-01-10 | Sender Gary Director | Purchase | +9,191 | $2.72 | $25K | 9,191 |
| 2024-11-21 | Parada Antonio Bernardino Guimaraes Director | Grant or award · Stock Option (right to buy) | +12,600 | 12,600 | ||
| 2024-11-21 | Sender Gary Director | Grant or award · Stock Option (right to buy) | +18,900 | 18,900 | ||
| 2024-11-21 | Schimmelpennink Evert B. Director | Grant or award · Stock Option (right to buy) | +18,900 | 18,900 | ||
| 2024-11-21 | Kropotova Alexandra Director | Grant or award · Stock Option (right to buy) | +18,900 | 18,900 | ||
| 2024-11-21 | Clark William D Director | Grant or award · Stock Option (right to buy) | +18,900 | 18,900 | ||
| 2024-11-21 | Arkowitz David Director | Grant or award · Stock Option (right to buy) | +12,600 | 12,600 |
Page 2 of 7 · 126 trades